tirzepatide for binge eating disorder Experts express alarm that GLP-1 RAs may trigger or worsen disorders. But is there any role they might play in eating disorder? And how can clinicians protect patients from risk? GLP-1 receptor agonists: A novel

Look through the pen window to ensure the solution is clear (or slightly yellow) and free from any particles or discolouration

The available evidence suggests that semaglutide does not directly reduce the effectiveness of tamoxifen in treating breast cancer

Emous M, van den Broek M, Wijma RB, de Heide LJM, van Dijk G, Laskewitz A, et al

As the pharmaceutical landscape evolves, tirzepatides robust clinical profile positions it as a frontrunner in addressing unmet needs in metabolic disorders, offering hope for patients and clinicians alike.

View Full Profile Rahul Guha, MD Ohio Neurology, Neurophysiology - Epilepsy, Seizures, Electroencephalogram, EEG, Prognosis of Cardiac Arrest, Traumatic Brain Injury, TBI, HIE, anoxic brain injury, Headache, Concussion, Coma, Anti-Seizure Drug Toxicity, Stroke, Dementia, Alzheimer's, Parkinson's, Seizures in Pregnancy, Seizure Meds causing fetal malformations Fellowship trained epilepsy neurologist in active clinical practice

Our specialists manage all interactions with insurers, allowing you to remain focused on achieving your health goals